Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE-SSc: UCMSC in Systemic Sclerosis
NCT04356287Phase 2Recruiting
- Start
- Jan 2023
- Primary completion
- Dec 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord-derived mesenchymal stromal cells in systemic sclerosis (SSc). Started Jan 2023; status: recruiting.
02
Drugs
umbilical cord-derived mesenchymal stromal cells
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT04356287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04356287.